Search details
1.
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Blood
; 133(22): 2427-2435, 2019 05 30.
Article
in English
| MEDLINE | ID: mdl-30917957
2.
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.
Int J Mol Sci
; 22(11)2021 Jun 03.
Article
in English
| MEDLINE | ID: mdl-34205175
3.
The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study.
Transpl Int
; 33(8): 936-947, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32314433
4.
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.
Br J Clin Pharmacol
; 85(12): 2747-2758, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31454097
5.
CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.
Am J Transplant
; 18(8): 1904-1913, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29377506
6.
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
Blood
; 125(15): 2397-404, 2015 Apr 09.
Article
in English
| MEDLINE | ID: mdl-25680756
7.
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.
Br J Clin Pharmacol
; 83(8): 1773-1781, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28230269
8.
CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.
Transpl Int
; 29(2): 184-95, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26369526
9.
ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation.
J Immunol
; 192(2): 741-51, 2014 Jan 15.
Article
in English
| MEDLINE | ID: mdl-24337742
10.
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Lancet Oncol
; 15(13): 1493-1502, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25456368
11.
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients.
Pharmacogenet Genomics
; 24(1): 26-34, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24322002
12.
Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.
Transpl Int
; 27(3): 271-9, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24279588
13.
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer.
Front Immunol
; 14: 1168444, 2023.
Article
in English
| MEDLINE | ID: mdl-37153618
14.
Relationship Between Antithymocyte Globulin Concentrations and Lymphocyte Sub-Populations in Kidney Transplant Patients.
Clin Pharmacokinet
; 61(1): 111-122, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34292526
15.
Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.
Antibodies (Basel)
; 11(3)2022 Aug 22.
Article
in English
| MEDLINE | ID: mdl-35997348
16.
The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
Front Immunol
; 11: 168, 2020.
Article
in English
| MEDLINE | ID: mdl-32117299
17.
Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study.
EClinicalMedicine
; 28: 100566, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33205032
18.
[The hinge region of therapeutic antibodies: major importance of a short sequence]. / La région charnière des anticorps thérapeutiques - L'importance capitale d'une courte séquence.
Med Sci (Paris)
; 35(12): 1098-1105, 2019 Dec.
Article
in French
| MEDLINE | ID: mdl-31903923
19.
Recombinant therapeutic monoclonal antibodies: mechanisms of action in relation to structural and functional duality.
Crit Rev Oncol Hematol
; 64(3): 226-33, 2007 Dec.
Article
in English
| MEDLINE | ID: mdl-17716905
20.
Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56dim Natural Killer Cells.
Front Immunol
; 8: 1556, 2017.
Article
in English
| MEDLINE | ID: mdl-29209315